| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |